日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

对一系列患者来源的异种移植瘤和细胞系进行基因组分析,发现伊沙匹隆是一种对抗化疗耐药性骨肉瘤的有效药物

Manara Maria Cristina, Bruzzese Francesca, Formentini Laura, Landuzzi Lorena, Pazzaglia Laura, Laginestra Maria Antonella, Carrabotta Marianna, Roca Maria Serena, Iannelli Federica, Grumetti Laura, Addi Laura, Parra Alessandro, Cristalli Camilla, Pasello Michela, Bavelloni Alberto, Carreras Francesca, Ruzzi Francesca, Bianchi Giuseppe, Gambarotti Marco, Righi Alberto, Budillon Alfredo, Lollini Pier-Luigi, Scotlandi Katia

PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD).

PD-L1 和 IFN-γ 调节非小细胞肺癌 (NSCLC) 细胞可塑性,与免疫检查点抑制剂 (ICI) 介导的超进展疾病 (HPD) 相关

Angelicola Stefania, Giunchi Francesca, Ruzzi Francesca, Frascino Mariateresa, Pitzalis Mary, Scalambra Laura, Semprini Maria Sofia, Pittino Olga Maria, Cappello Chiara, Siracusa Irene, Chillico Ilaria Candida, Di Noia Martina, Turato Cristian, De Siervi Silvia, Lescai Francesco, Ciavattini Teresa, Lopatriello Giulia, Bertoli Luca, De Jonge Hugo, Iamele Luisa, Altimari Annalisa, Gruppioni Elisa, Ardizzoni Andrea, Rossato Marzia, Gelsomino Francesco, Lollini Pier-Luigi, Palladini Arianna

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

通过创新的基于 cVLP 的疫苗靶向 PCSK9,增强了 cVLP-HER2 疫苗在 HER2 阳性乳腺癌临床前模型中的治疗活性

Scalambra Laura, Ruzzi Francesca, Pittino Olga Maria, Semprini Maria Sofia, Cappello Chiara, Angelicola Stefania, Palladini Arianna, Nanni Patrizia, Goksøyr Louise, Fougeroux Cyrielle, Penichet Manuel L, Sander Adam Frederik, Lollini Pier-Luigi

Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches

软骨肉瘤:新的分子见解、近患者临床前建模的挑战和治疗方法

Landuzzi, Lorena; Ruzzi, Francesca; Lollini, Pier-Luigi; Scotlandi, Katia

Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response

构建表达食蟹猴(Macaca fascicularis)HER2的细胞模型,用于功能性评估抗人HER2抗体的交叉反应性。

Cappello, Chiara; Ruzzi, Francesca; Consoli, Julia; Semprini, Maria Sofia; Scalambra, Laura; Pittino, Olga Maria; Angelicola, Stefania; Palladini, Arianna; Thorn, Mette; Nanni, Patrizia; Lollini, Pier-Luigi

Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?

脂筏、小窝和表皮生长因子受体家族:是朋友还是敌人?

Ruzzi, Francesca; Cappello, Chiara; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Pittino, Olga Maria; Landuzzi, Lorena; Palladini, Arianna; Nanni, Patrizia; Lollini, Pier-Luigi

Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations

EGFR酪氨酸激酶抑制剂在携带BRAF 3类突变的非小细胞肺癌中的临床和临床前活性

Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, Beatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco

IL-1 Family Members in Bone Sarcomas

骨肉瘤中的IL-1家族成员

Landuzzi, Lorena; Ruzzi, Francesca; Pellegrini, Evelin; Lollini, Pier-Luigi; Scotlandi, Katia; Manara, Maria Cristina

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

用于癌症免疫疗法的病毒样颗粒(VLP)疫苗

Ruzzi, Francesca; Semprini, Maria Sofia; Scalambra, Laura; Palladini, Arianna; Angelicola, Stefania; Cappello, Chiara; Pittino, Olga Maria; Nanni, Patrizia; Lollini, Pier-Luigi

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research

滑膜肉瘤临床前模型:整合转基因小鼠模型和患者来源模型进行转化研究

Landuzzi, Lorena; Ruzzi, Francesca; Lollini, Pier-Luigi; Scotlandi, Katia